SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Sheng Deng, Xiong Deng, Lamei Yuan, Zhi Song, Zhijian Yang, Wei Xiong, Hao Deng, Genetic analysis of SNCA coding mutation in Chinese Han patients with Parkinson disease, Acta Neurologica Belgica, 2014,

    CrossRef

  2. 2
    M. Bozi, D. Papadimitriou, R. Antonellou, M. Moraitou, M. Maniati, D. K. Vassilatis, S. G. Papageorgiou, A. Leonardos, G. Tagaris, G. Malamis, D. Theofilopoulos, S. Kamakari, E. Stamboulis, G. M. Hadjigeorgiou, A. Athanassiadou, H. Michelakakis, A. Papadimitriou, T. Gasser, L. Stefanis, Genetic assessment of familial and early-onset Parkinson's disease in a Greek population, European Journal of Neurology, 2014, 21, 7
  3. 3
    Hao Deng, Lamei Yuan, Genetic variants and animal models in SNCA and Parkinson disease, Ageing Research Reviews, 2014, 15, 161

    CrossRef

  4. 4
    Ryan D. Mills, Terrence D. Mulhern, Fei Liu, Janetta G. Culvenor, Heung-Chin Cheng, Prediction of the Repeat Domain Structures and Impact of Parkinsonism-Associated Variations on Structure and Function of all Functional Domains of Leucine-Rich Repeat Kinase 2 (LRRK2), Human Mutation, 2014, 35, 4
  5. 5
    Huajun Jin, Arthi Kanthasamy, Vellareddy Anantharam, Anumantha G. Kanthasamy, Biomarkers in Toxicology, 2014,

    CrossRef

  6. 6
    Xi Wu, Ke-Fu Tang, Yang Li, Yu-Yu Xiong, Lu Shen, Zhi-Yun Wei, Ke-Jun Zhou, Jia-Min Niu, Xia Han, Lun Yang, Guo-Yin Feng, Lin He, Sheng-Ying Qin, Quantitative assessment of the effect of LRRK2 exonic variants on the risk of Parkinson’s disease: A meta-analysis, Parkinsonism & Related Disorders, 2012, 18, 6, 722

    CrossRef

  7. 7
    Christine Klein, Rosalind Chuang, Connie Marras, Anthony E. Lang, The curious case of phenocopies in families with genetic Parkinson's disease, Movement Disorders, 2011, 26, 10
  8. 8
    Kumar M Prakash, Eng-King Tan, Development of Parkinson’s disease biomarkers, Expert Review of Neurotherapeutics, 2010, 10, 12, 1811

    CrossRef

  9. 9
    Andreas Plaitakis, Helen Latsoudis, Konstantinos Kanavouras, Beate Ritz, Jeff M Bronstein, Irene Skoula, Vasileios Mastorodemos, Spyridon Papapetropoulos, Nikolas Borompokas, Ioannis Zaganas, Georgia Xiromerisiou, George M Hadjigeorgiou, Cleanthe Spanaki, Gain-of-function variant in GLUD2 glutamate dehydrogenase modifies Parkinson's disease onset, European Journal of Human Genetics, 2010, 18, 3, 336

    CrossRef

  10. 10
    Georgia Xiromerisiou, Efthimios Dardiotis, Vaïa Tsimourtou, Persa Maria Kountra, Konstantinos N. Paterakis, Eftychia Z. Kapsalaki, Kostas N. Fountas, Georgios M. Hadjigeorgiou, Genetic basis of Parkinson disease, Neurosurgical FOCUS, 2010, 28, 1, E7

    CrossRef

  11. 11
    Karen Nuytemans, Jessie Theuns, Marc Cruts, Christine Van Broeckhoven, Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update, Human Mutation, 2010, 31, 7
  12. 12
    L. Correia Guedes, J.J. Ferreira, M.M. Rosa, M. Coelho, V. Bonifati, C. Sampaio, Worldwide frequency of G2019S LRRK2 mutation in Parkinson's disease: A systematic review, Parkinsonism & Related Disorders, 2010, 16, 4, 237

    CrossRef

  13. 13
    Anna De Rosa, Chiara Criscuolo, Pietro Mancini, Marina De Martino, Ilaria Anna Giordano, Sabina Pappatà, Alessandro Filla, Giuseppe De Michele, Genetic screening for LRRK2 gene G2019S mutation in Parkinson's disease patients from Southern Italy, Parkinsonism & Related Disorders, 2009, 15, 3, 242

    CrossRef

  14. You have free access to this content14
    Payal N. Gandhi, Shu G. Chen, Amy L. Wilson-Delfosse, Leucine-rich repeat kinase 2 (LRRK2): A key player in the pathogenesis of Parkinson's disease, Journal of Neuroscience Research, 2009, 87, 6
  15. 15
    Coro Paisán-Ruiz, LRRK2 gene variation and its contribution to Parkinson disease, Human Mutation, 2009, 30, 8
  16. 16
    S. Lesage, A. Brice, Parkinson's disease: from monogenic forms to genetic susceptibility factors, Human Molecular Genetics, 2009, 18, R1, R48

    CrossRef

  17. 17
    Spiridon Papapetropoulos, Nikhil Adi, Lina Shehadeh, Nanette Bishopric, Carlos Singer, Andreas A Argyriou, Elizabeth Chroni, Is the G2019S LRRK2 mutation common in all southern European populations?, Journal of Clinical Neuroscience, 2008, 15, 9, 1027

    CrossRef

  18. 18
    Joaquim J. Ferreira, Leonor Correia Guedes, Mário Miguel Rosa, Miguel Coelho, Marina van Doeselaar, Dorothea Schweiger, Alessio Di Fonzo, Ben A. Oostra, Cristina Sampaio, Vincenzo Bonifati, High prevalence of LRRK2 mutations in familial and sporadic Parkinson's disease in Portugal, Movement Disorders, 2007, 22, 8
  19. 19
    S. Papapetropoulos, A. A. Argyriou, G. Mitsi, E. Chroni, The G2019S LRRK2 mutation is uncommon amongst Greek patients with familial Parkinson's disease, European Journal of Neurology, 2007, 14, 11
  20. 20
    K. Kalinderi, L. Fidani, S. Bostantjopoulou, Z. Katsarou, A. Kotsis, The G2019S LRRK2 mutation is uncommon amongst Greek patients with sporadic Parkinson's disease, European Journal of Neurology, 2007, 14, 10